<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>liquid biopsy diagnostics &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/liquid-biopsy-diagnostics/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 21:19:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>liquid biopsy diagnostics &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Advancing Surgical Approaches for Hepatocellular Carcinoma</title>
		<link>https://bioengineer.org/advancing-surgical-approaches-for-hepatocellular-carcinoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 21:18:40 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cerrahi yaklaşımların geliştirilmesi). 3. **]]></category>
		<category><![CDATA[HCC surgical treatments]]></category>
		<category><![CDATA[Hepatocellular Carcinoma]]></category>
		<category><![CDATA[hepatocellular carcinoma surgical innovations]]></category>
		<category><![CDATA[liquid biopsy diagnostics]]></category>
		<category><![CDATA[liquid biopsy for HCC recurrence monitoring]]></category>
		<category><![CDATA[multidisciplinary cancer care **Açıklama:** 1. **Hepatocellular carcinoma:** Makalenin ana konusu. 2. **HCC surgical treatments:** Başlık ve içeriğin temel odağı (rezeksiyon]]></category>
		<category><![CDATA[multidisciplinary HCC treatment strategies]]></category>
		<category><![CDATA[perioperative immunotherapy in liver cancer]]></category>
		<category><![CDATA[precision oncology for hepatocellular carcinoma]]></category>
		<category><![CDATA[precision oncology HCC]]></category>
		<category><![CDATA[transplantasyon]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advancing-surgical-approaches-for-hepatocellular-carcinoma/</guid>

					<description><![CDATA[Hepatocellular carcinoma (HCC), which emerges as the predominant form of liver cancer worldwide, is recognized as a leading contributor to cancer-related mortality. The challenge in effectively managing this malignancy is exacerbated by the typically high recurrence rates after surgical interventions, such as resection, which can surge to approximately 70% within a five-year time frame. Additionally, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319159</post-id>	</item>
		<item>
		<title>Inside City of Hope: Research Highlights from July 2025</title>
		<link>https://bioengineer.org/inside-city-of-hope-research-highlights-from-july-2025/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 08 Aug 2025 05:36:24 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[biomedical innovation]]></category>
		<category><![CDATA[cancer clinical trials 2025]]></category>
		<category><![CDATA[health disparities in oncology]]></category>
		<category><![CDATA[immune system recovery]]></category>
		<category><![CDATA[liquid biopsy diagnostics]]></category>
		<guid isPermaLink="false">https://bioengineer.org/inside-city-of-hope-research-highlights-from-july-2025/</guid>

					<description><![CDATA[City of Hope is at the forefront of biomedical innovation, unveiling a series of pioneering clinical investigations and scientific breakthroughs that have the potential to transform cancer treatment and improve patient outcomes. These endeavors include novel drug trials targeting some of the most aggressive cancers, cutting-edge diagnostic technologies, and profound discoveries into the mechanisms of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">254621</post-id>	</item>
	</channel>
</rss>
